Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine A Janeway

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
JCO Oncology Advances|May 14, 2026
PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network StudyDamon R Reed, Katherine A Janeway, Charles G Minard, et al.
JAMA Oncology|March 25, 2016
Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor ClinicSosipatros A Boikos, Alberto S Pappo, J Keith Killian, et al.
Communications Biology|July 26, 2019
Canine osteosarcoma genome sequencing identifies recurrent mutations in <i>DMD</i> and the histone methyltransferase gene <i>SETD2</i>Heather L Gardner, Karthigayini Sivaprakasam, Natalia Briones, et al.
International Journal of Radiation Oncology, Biology, Physics|November 24, 2025
Factors Associated With Primary Site Local Therapy in Patients With Nonmetastatic Ewing Sarcoma Treated With Interval-Compressed Chemotherapy: A Report From the Children's Oncology GroupSafia K Ahmed, Odion Binitie, Mark Krailo, et al.
Cancer|May 12, 2017
Clinical trial enrollment of adolescents and young adults with sarcomaLara E Davis, Katherine A Janeway, Aaron R Weiss, et al.
Communications Medicine|January 22, 2026
Introducing iCatalog as a clinical decision support tool for collaborative pediatric precision oncology studiesWenjun Kang, Lorena Lazo de la Vega, Hannah Comeau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2016
Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology GroupKieuhoa T Vo, Jeremy V Edwards, C Lorrie Epling, et al.
Pediatric Blood & Cancer|July 21, 2020
The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumorKevin X Liu, Natalie B Collins, Katie A Greenzang, et al.
The New England Journal of Medicine|November 24, 2021
Belzutifan, a Potent HIF2α Inhibitor, in the Pacak-Zhuang SyndromeJunne Kamihara, Kayla V Hamilton, Jessica A Pollard, et al.
Pediatric Blood & Cancer|May 26, 2025
Preoperative Radiotherapy in Patients With Localized Ewing Sarcoma Enrolled on AEWS1031: A Report From the Children's Oncology GroupDaniel J Indelicato, Alexandra K Callan, Safia K Ahmed, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
JCO Oncology Advances|May 14, 2026
PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network StudyDamon R Reed, Katherine A Janeway, Charles G Minard, et al.
JAMA Oncology|March 25, 2016
Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor ClinicSosipatros A Boikos, Alberto S Pappo, J Keith Killian, et al.
Communications Biology|July 26, 2019
Canine osteosarcoma genome sequencing identifies recurrent mutations in <i>DMD</i> and the histone methyltransferase gene <i>SETD2</i>Heather L Gardner, Karthigayini Sivaprakasam, Natalia Briones, et al.
International Journal of Radiation Oncology, Biology, Physics|November 24, 2025
Factors Associated With Primary Site Local Therapy in Patients With Nonmetastatic Ewing Sarcoma Treated With Interval-Compressed Chemotherapy: A Report From the Children's Oncology GroupSafia K Ahmed, Odion Binitie, Mark Krailo, et al.
Cancer|May 12, 2017
Clinical trial enrollment of adolescents and young adults with sarcomaLara E Davis, Katherine A Janeway, Aaron R Weiss, et al.
Communications Medicine|January 22, 2026
Introducing iCatalog as a clinical decision support tool for collaborative pediatric precision oncology studiesWenjun Kang, Lorena Lazo de la Vega, Hannah Comeau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2016
Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology GroupKieuhoa T Vo, Jeremy V Edwards, C Lorrie Epling, et al.
Pediatric Blood & Cancer|July 21, 2020
The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumorKevin X Liu, Natalie B Collins, Katie A Greenzang, et al.
The New England Journal of Medicine|November 24, 2021
Belzutifan, a Potent HIF2α Inhibitor, in the Pacak-Zhuang SyndromeJunne Kamihara, Kayla V Hamilton, Jessica A Pollard, et al.
Pediatric Blood & Cancer|May 26, 2025
Preoperative Radiotherapy in Patients With Localized Ewing Sarcoma Enrolled on AEWS1031: A Report From the Children's Oncology GroupDaniel J Indelicato, Alexandra K Callan, Safia K Ahmed, et al.
Pageof 15